Molina Healthcare, Inc. financial data

Symbol
MOH on NYSE
Location
200 Oceangate, Suite 100, Long Beach, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Jul 25, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 152 % +2.63%
Debt-to-equity 247 % -18.7%
Return On Assets 7.03 % +0.14%
Operating Margin 4.1 % 0%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 58.6M shares +0.52%
Common Stock, Shares, Outstanding 59M shares +1.72%
Weighted Average Number of Shares Outstanding, Basic 58.1M shares +0.69%
Weighted Average Number of Shares Outstanding, Diluted 58.2M shares +0.52%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 37.4B USD +14.7%
General and Administrative Expense 2.66B USD +10.7%
Costs and Expenses 35.9B USD +14.7%
Operating Income (Loss) 1.54B USD +14.7%
Nonoperating Income (Expense) -109M USD +0.91%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.43B USD +16.1%
Income Tax Expense (Benefit) 363M USD +16.3%
Net Income (Loss) Attributable to Parent 1.06B USD +16%
Earnings Per Share, Basic 18.4 USD/shares +15.2%
Earnings Per Share, Diluted 18.2 USD/shares +15.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.35B USD -11.3%
Marketable Securities, Current 4.35B USD +11.9%
Assets, Current 12.3B USD +7.78%
Deferred Income Tax Assets, Net 232M USD +5.46%
Other Assets, Noncurrent 136M USD +15.3%
Assets 15.2B USD +11.2%
Contract with Customer, Liability, Current 13M USD -96.9%
Liabilities, Current 7.84B USD +3.97%
Other Liabilities, Noncurrent 122M USD 0%
Liabilities 10.3B USD +3.01%
Accumulated Other Comprehensive Income (Loss), Net of Tax -85M USD +41.8%
Retained Earnings (Accumulated Deficit) 4.49B USD +31%
Stockholders' Equity Attributable to Parent 4.84B USD +33.7%
Liabilities and Equity 15.2B USD +11.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.42B USD -10.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1.12B USD +25.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%